CBLL Share Price Performance
US$0
-23.34 (-100.00%)
Price US$0
Fair ValueUS$27.00
Share Pricen/a
CeriBell, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
CBLL Community Narratives
AN
Fair Value US$27 34.2% undervalued intrinsic discount
AI Neuromonitoring Expansion Will Drive Long-Term Opportunity In Acute And Pediatric Care
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AI Neuromonitoring Expansion Will Drive Long-Term Opportunity In Acute And Pediatric Care
Catalysts About CeriBell CeriBell provides rapid, AI enabled point of care EEG solutions to improve seizure detection and neurological monitoring in acute care settings. What are the underlying business or industry changes driving this perspective?Read more
3
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$27
34.2% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Profit Margin
12.91%
Future PE
60.61x
Price in 2028
US$33.75
Trending Discussion
Recently Updated Narratives
AN
AI Neuromonitoring Expansion Will Drive Long-Term Opportunity In Acute And Pediatric Care
Fair Value: US$27 34.2% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
CeriBell, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -1.42
- 87.89%
- -59.97%
- 12.8%
About CBLL
- Founded
- 2014
- Employees
- 327
- CEO
- WebsiteView website
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
